We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmakers Invoke Federal March-In Rights to Fuel Xtandi Generics
Lawmakers Invoke Federal March-In Rights to Fuel Xtandi Generics
More than two dozen lawmakers are asking HHS Secretary Xavier Becerra to lower the cost of Xtandi (enzalutamide), a pricey androgen-blocker developed by Astellas and Pfizer used as maintenance therapy for people with prostate cancer.